Form 13-F position report

BIOGEN INC

Reported by JANUS HENDERSON INVESTORS US LLC

BIIB CUSIP 09062X103 Manager CIK 0000812295

Reported 803,357 shares, down 94,703 (10.5%) from the prior quarter.

Reported value -16.9%; share count -10.5% vs. the prior quarter.

Reduced
% of reported 13F value 0.17% This manager · Q2 2016
Shares 803,357 Quarter-end amount reported
Reported value $194,253,000 Fair value at quarter end
Consecutive quarters held 13 Through Q2 2016

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2013-06-30 175089000
2013-09-30 256014000
2013-12-31 392294000
2014-03-31 676391000
2014-06-30 726354000
2014-09-30 752786000
2014-12-31 909683000
2015-03-31 920672000
2015-06-30 896474000
2015-09-30 585030000
2015-12-31 302405000
2016-03-31 233834000
2016-06-30 194253000
2016-09-30 203345000
2016-12-31 180245000
2017-03-31 529524000

Quarterly position history

How this manager's reported quarter-end position changed over time.

16 quarters
Quarterly reported position history for BIOGEN INC held by JANUS HENDERSON INVESTORS US LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2017 Added 1,936,719 +1,301,251 (204.8%) 0.43% $529,524,000 2017-05-16
Q4 2016 Reduced 635,468 -14,130 (-2.2%) 0.15% $180,245,000 2017-02-14
Q3 2016 Reduced 649,598 -153,759 (-19.1%) 0.17% $203,345,000 2016-11-14
Q2 2016 Reduced 803,357 -94,703 (-10.5%) 0.17% $194,253,000 2016-08-12
Q1 2016 Reduced 898,060 -89,123 (-9.0%) 0.2% $233,834,000 2016-05-16
Q4 2015 Reduced 987,183 -1,017,617 (-50.8%) 0.26% $302,405,000 2016-02-16
Q3 2015 Reduced 2,004,800 -214,710 (-9.7%) 0.52% $585,030,000 2015-11-17
Q2 2015 Added 2,219,510 +39,233 (1.8%) 0.74% $896,474,000 2015-08-17
Q1 2015 Reduced 2,180,277 -499,445 (-18.6%) 0.76% $920,672,000 2015-05-15
Q4 2014 Added 2,679,722 +404,124 (17.8%) 0.78% $909,683,000 2015-02-18
Q3 2014 Reduced 2,275,598 -31,053 (-1.3%) 0.69% $752,786,000 2014-11-14
Q2 2014 Added 2,306,651 +95,271 (4.3%) 0.67% $726,354,000 2014-08-14
Q1 2014 Added 2,211,380 +809,076 (57.7%) 0.63% $676,391,000 2014-05-15
Q4 2013 Added 1,402,304 +338,946 (31.9%) 0.37% $392,294,000 2014-02-14
Q3 2013 Added 1,063,358 +249,748 (30.7%) 0.25% $256,014,000 2013-11-14
Q2 2013 Reduced 813,610 -962,136 (-54.2%) 0.18% $175,089,000 2013-08-14

Who else reported the position

837 managers reported BIOGEN INC for Q2 2016.

Managers reporting BIOGEN INC in Q2 2016.
Manager Activity Shares Change % of reported 13F Reported value Tenure
PRIMECAP MANAGEMENT CO CA Reduced 16,024,861 -221,865 4.13% $3,875,132,000 13 qtrs
VANGUARD GROUP INC Added 13,544,616 +182,714 0.2% $3,275,359,000 13 qtrs
FMR LLC Reduced 11,442,148 -2,050,916 0.38% $2,766,940,000 13 qtrs
STATE STREET CORPORATION Reduced 8,833,348 -95,507 0.23% $2,136,074,000 13 qtrs
Clearbridge Investments LLC Reduced 8,271,679 -193,780 2.36% $2,000,258,000 13 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 6,366,152 -1,753,757 0.33% $1,539,463,000 13 qtrs
BlackRock Institutional Trust Company N A Added 5,816,485 +50,433 0.23% $1,406,542,000 13 qtrs
BlackRock Fund Advisors Added 4,843,447 +71,709 0.26% $1,171,242,000 13 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 4,811,659 +153,390 0.3% $1,163,555,000 13 qtrs
Invesco Ltd Added 4,096,693 +481,145 0.36% $990,661,000 13 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2016
Filed
August 12, 2016
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
718,168
Shared
0
None
85,189

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.